Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response (Q56828560)

Europe PubMed Central

title

Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response (English)

0 references

Lars L. Gustafsson

5

0 references

author name string

Hans-Georg Eichler

1

0 references

Eric Abadie

2

0 references

Alasdair Breckenridge

3

0 references

Bruno Flamion

4

0 references

Hubert Leufkens

6

0 references

Malcolm Rowland

7

0 references

Christian K. Schneider

8

0 references

Brigitte Bloechl-Daum

Nature Reviews Drug Discovery

9

0 references

publication date

July 2011

0 references

published in

0 references

volume

10

0 references

page(s)

495-506

0 references

issue

7

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/nrd3501

0 references

cites work

EBM, HTA, and CER: clearing the confusion

1 reference

More on subgroup analyses in clinical trials

21 January 2018

1 reference

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy

21 January 2018

1 reference

Pharmacogenetics in drug discovery and development: a translational perspective

21 January 2018

1 reference

Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population

21 January 2018

1 reference

Off-label drug use among hospitalised children: identifying areas with the highest need for research

21 January 2018

1 reference

Guidance for off-label use of drugs

21 January 2018

1 reference

Risk/benefit evaluation of drugs: the role of the pharmaceutical industry in Germany

21 January 2018

1 reference

The safety of newly approved medicines: do recent market removals mean there is a problem?

21 January 2018

1 reference

Integrating molecular diagnostics into anticancer drug discovery.

21 January 2018

1 reference

Changes in prescribed drug doses after market introduction

21 January 2018

1 reference

Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999.

21 January 2018

1 reference

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

21 January 2018

1 reference

Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.

21 January 2018

1 reference

Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.

21 January 2018

1 reference

Adjustment of dosing of antimicrobial agents for bodyweight in adults.

21 January 2018

1 reference

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example

21 January 2018

1 reference

Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides

21 January 2018

1 reference

Fruit juice inhibition of uptake transport: a new type of food-drug interaction

21 January 2018

1 reference

Off-label prescribing among office-based physicians

21 January 2018

1 reference

Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study

21 January 2018

1 reference

Topiramate in non-approved indications and acute myopia or angle closure glaucoma

21 January 2018

1 reference

What information do patients need about medicines? Perspectives from the pharmaceutical industry

21 January 2018

1 reference

The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response

21 January 2018

1 reference

Treatment adherence and risk of death after a myocardial infarction

21 January 2018

1 reference

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review

21 January 2018

1 reference

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses

21 January 2018

1 reference

Modelling the association between adherence and viral load in HIV-infected patients.

21 January 2018

1 reference

Patient adherence to prescribed antimicrobial drug dosing regimens

21 January 2018

1 reference

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

21 January 2018

1 reference

Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.

21 January 2018

1 reference

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog

21 January 2018

1 reference

Factors that can affect the external validity of randomised controlled trials

21 January 2018

1 reference

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

21 January 2018

1 reference

Enrichment of clinical study populations

21 January 2018

1 reference

Regulatory policies on medicines for psychiatric disorders: is Europe on target?

21 January 2018

1 reference

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

21 January 2018

1 reference

Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact.

21 January 2018

1 reference

Using numerical results from systematic reviews in clinical practice

21 January 2018

1 reference

Assessing the clinical utility of diagnostics used in drug therapy

21 January 2018

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.

21 January 2018

1 reference

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

21 January 2018

1 reference

The long and winding road to warfarin pharmacogenetic testing.

21 January 2018

1 reference

Pharmacogenetics of warfarin

21 January 2018

1 reference

Personalized medicine in oncology: the future is now.

21 January 2018

1 reference

An accelerated pathway for targeted cancer therapies.

21 January 2018

1 reference

Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems

21 January 2018

1 reference

Role of modelling and simulation in Phase I drug development

21 January 2018

1 reference

Proposals for model-based paediatric medicinal development within the current European Union regulatory framework

21 January 2018

1 reference

How to reduce prescribing errors

21 January 2018

1 reference

Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies

21 January 2018

1 reference

The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

21 January 2018

1 reference

Accelerating the Use of Electronic Health Records in Physician Practices

21 January 2018

1 reference

Design and implementation of a point-of-care computerized system for drug therapy in Stockholm metropolitan health region--Bridging the gap between knowledge and practice.

21 January 2018

1 reference

Evaluation and certification of computerized provider order entry systems.

21 January 2018

1 reference

SFINX—a drug-drug interaction database designed for clinical decision support systems

21 January 2018

1 reference

The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months

21 January 2018

1 reference

Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics

21 January 2018

1 reference

Tuberculosis in New York City--turning the tide

21 January 2018

1 reference

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial

21 January 2018

1 reference

Mobile phones to improve HIV treatment adherence

21 January 2018

1 reference

Self-titration for treatment of uncomplicated hypertension

21 January 2018

1 reference

Pragmatic trials--guides to better patient care?

21 January 2018

1 reference

Off-label prescribing in oncology

21 January 2018

1 reference

Usage, risk, and benefit of weight-loss drugs in primary care

31 March 2020

1 reference

Body mass index and clinical response to infliximab in rheumatoid arthritis

31 March 2020

1 reference

Chronobiology. Suggestions for integrating it into drug development

31 March 2020

1 reference

Rethinking therapeutic cancer vaccines

31 March 2020

1 reference

Biomarkers for Alzheimer's disease therapeutic trials

31 March 2020

1 reference

Relative effectiveness assessment of listed drugs (REAL): a new method for an early comparison of the effectiveness of approved health technologies

31 March 2020

1 reference

Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology

31 March 2020

1 reference

Contraindicated use of cisapride: impact of food and drug administration regulatory action

31 March 2020

1 reference

Thinking outside the pillbox--medication adherence as a priority for health care reform

31 March 2020

1 reference

Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way?

31 March 2020

1 reference

Impact of medication adherence on hospitalization risk and healthcare cost

31 March 2020

1 reference

31 March 2020

2009 FDA drug approvals

1 reference

New drug approval success rate in Europe in 2009

31 March 2020

1 reference

HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment

31 March 2020

1 reference

12 December 2020

Variability in patterns of drug usage

1 reference

12 December 2020

e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers

1 reference

12 December 2020

How a statin might destroy a drug company

1 reference

12 December 2020